Total amount raised
$9.6 Millions
Latest funding date
07/01/2023
Location
Leucine has successfully raised funding to support its AI-powered solutions for the pharmaceutical industry. The platform integrates manufacturing, quality, and laboratory operations into a cohesive digital ecosystem.
Keep reading to explore the intricacies of Leucine's fundraising journey and the investors backing this innovative platform.
What Is Leucine?
Leucine, founded in 2018, is headquartered in New York. The company was established by founders Prashant Kumar and Sandeep Kumar.
Leucine specializes in providing AI-powered solutions for the pharmaceutical industry, integrating manufacturing, quality, and laboratory operations into a cohesive digital ecosystem.
With a team of over 50 employees, Leucine is dedicated to optimizing processes, ensuring compliance, and driving operational excellence in the pharmaceutical sector.
How Much Funding Has Leucine Raised?
- Series A Funding Round
- Amount Raised: $7 million
- Date: October 2023
- Lead Investors: Ecolab Inc.
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Leucine's platform with more solutions to improve compliance and productivity across the pharmaceutical manufacturing ecosystem.
Leucine has raised a total of $7 million in funding. The current valuation is not publicly disclosed.
Key Investors
- Ecolab Inc.
- Details: Ecolab Inc. is a global leader in water, hygiene, and energy technologies and services. They provide comprehensive solutions and on-site services to promote safe food, maintain clean environments, and optimize water and energy use.
- Investment Focus Areas: Pharmaceuticals, food safety, water treatment.
- Notable Investments: Nalco Water, Anios, Purolite.
- Pravega Ventures
- Details: Pravega Ventures is an early-stage venture capital firm based in India. They focus on investing in technology-driven startups with high growth potential.
- Investment Focus Areas: Technology, healthcare, consumer internet.
- Notable Investments: HealthifyMe, MoneyTap, BetterPlace.
- Axilor Ventures
- Details: Axilor Ventures is an accelerator and early-stage venture capital firm. They support startups through funding, mentorship, and market access.
- Investment Focus Areas: Technology, healthcare, fintech.
- Notable Investments: FreshToHome, Portea Medical, UrbanPiper.
- Techstars
- Details: Techstars is a global platform for investment and innovation. They run accelerator programs and invest in startups across various sectors.
- Investment Focus Areas: Technology, healthcare, fintech.
- Notable Investments: SendGrid, Sphero, DigitalOcean.
- Angel Investors
- Details: Angel investors are high-net-worth individuals who provide capital for startups in exchange for ownership equity or convertible debt. They often bring valuable industry experience and networks.
- Investment Focus Areas: Varies widely depending on the individual investor.
- Notable Investments: Not publicly disclosed.
What's Next for Leucine?
Leucine stands at the cusp of a significant opportunity in the pharmaceutical industry. With its AI-powered compliance platform, the company can tap into a vast market of pharmaceutical manufacturers still reliant on outdated paper-based systems. This shift towards digitization and automation is not just a trend but a necessity, offering Leucine a chance to expand its customer base and enhance manufacturing efficiency.
Future fundraising opportunities appear promising, especially given the recent successful Series A round. As Leucine continues to demonstrate its value, it may attract further investments to scale operations and refine its technology. However, the company must navigate challenges such as competition from legacy systems and the need for continuous innovation to stay ahead.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Leucine and gather other critical business insights.
Sign up for free on Clay and start transforming your sales strategy today.
